Navigation Links
Gamida Cell Announces Feasibility Study With Weill Cornell Medical College
Date:12/2/2009

JERUSALEM, Israel, December 2 /PRNewswire/ -- Gamida Cell announced today a feasibility study evaluating the preclinical (animal study) safety and efficacy of a gene therapy product which combines technology from Weill Cornell Medical College and Gamida Cell. The product may have potential to treat inherited anemias such as Cooley's Anemia.

Gamida Cell is developing a series of technologies to expand, ex vivo, populations of stem/progenitor cells. The company's lead product, StemEx(R), comprised of expanded populations of adult stem cells derived from umbilical cord blood (UCB), is used today as an experimental treatment for blood cancers like leukemia and lymphoma (see ExCell trial at http://www.stemexstudy.com).

Using lentivirus-based gene transfer, Weill Cornell is researching methods to successfully transfer intactglobin genes, coding for functional hemoglobin proteins, into hematopoietic (blood) stem cells with the goal of developing a cure for beta-thalassemia, generally known as Cooley's anemia and Sickle cell anemia. These are the most commonly inherited diseases.

"The current treatment for Cooley's and sickle cell anemia is chronic blood transfusion, which is used to prevent an otherwise likely fatal outcome. Stem cell-based gene transfer, an ex vivo procedure commonly known as transduction, offers a potential means to cure these diseases through the permanent integration of potentially therapeutic genes into the hematopoietic stem cells of the patient. The limitation of this therapy is the low number of transduced stem cells. Expanding the number of transduced stem cells in vitro before reinfusion offers the possibility of creating a more effective therapy and consequently, a potential cure. Using Gamida Cell's expansion technology, we hope to transfer a substantively increased number of stem cells, transduced with an intact gl
'/>"/>

SOURCE Gamida Cell LTD
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Gamida Cell and Cellerix Partner on Feasibility Study
2. CryoLife Expands Distribution of Hemostase MPH(R) to France through Laboratoire Gamida
3. Simcere Announces 105 Drugs Included in Chinas National Drug Reimbursement List
4. Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia
5. PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT
6. Ohio Capital Fund Announces Sponsorship of Minority Business Conference
7. Cadient Interactive Announces the Launch of HATCH Consulting Services
8. Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics
9. The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinsons Disease Treatments
10. ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ
11. Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2010)... 2010 SynCo Bio Partners today,announced an ... recent initiation of a Phase 1 clinical trial in ... VRS-859. This news,comes less than 12 months since the ... product VRS-859 (exenatide-XTEN). , ... ...
(Date:7/29/2010)... , July 29 Isis Pharmaceuticals, Inc. (Nasdaq: ... $5 million milestone payment from GlaxoSmithKline (NYSE: GSK ... drug to treat an undisclosed rare and serious disease.  Isis will ... has the option to license it.   , ... "We are pleased to have ...
(Date:7/28/2010)... Bioengineers at the University of California, San Diego and ... wireless telemetry system that continuously monitors tissue glucose and ... published in the July 28, 2010 issue of the ... of this glucose-sensing device as an implant in animals ... FDA approval, the device may be useful to people ...
(Date:7/28/2010)... Burrill & Company, a San Francisco -based global leader in ... and Media, is pleased to announce that Shawn Cross ... immediately. , , , ... Cross will lead the Merchant Banking Group,s strategic growth plan, which ... needs of its clients at various stages in their growth. These ...
Breaking Biology Technology:SynCo Bio Partners and Versartis Expand Collaboration as Lead Product Enters into Clinical Trials 2SynCo Bio Partners and Versartis Expand Collaboration as Lead Product Enters into Clinical Trials 3Isis Earns $5 Million Milestone Payment From GSK for Designation of a Development Candidate to Treat an Undisclosed Rare and Serious Disease 2Isis Earns $5 Million Milestone Payment From GSK for Designation of a Development Candidate to Treat an Undisclosed Rare and Serious Disease 3Implanted glucose sensor works for more than 1 year 2Implanted glucose sensor works for more than 1 year 3Implanted glucose sensor works for more than 1 year 4Shawn Cross Appointed CEO of Burrill Merchant Banking Group 2Shawn Cross Appointed CEO of Burrill Merchant Banking Group 3
... at an annual clip of 16 percent the past two ... historically known for beer, brats, and milk, says Gale Davy, ... State Capitol in Madison. , ,"Can you think of ... is the executive director of the Wisconsin Association for ...
... a Wisconsin company specializing in functional Magnetic Resonance Imaging ... and Drug Administration (FDA) issued a Special 510(k) approval ... MindState fDAD had previously received clearance in February 2005 ... allows Neurognostics to enhance fDAD by providing a library ...
... DirectorConnector , that connects businesses and non-profit organizations ... users, according to the two firms that started it ... LLP and the accounting firm of ... organizations in need of specially-skilled board members with qualified ...
Other Biology Technology:Bioscience beats beer 2
(Date:7/29/2010)... 2010): Today, the Association for Molecular Pathology (AMP) submitted ... made by the National Institutes of Health (NIH) for ... survey of its membership to formulate a comprehensive response ... respondents working in a clinical laboratory setting, AMP is ... to the GTR, including insight to the community,s concerns ...
(Date:7/29/2010)... (July 29, 2010) While pundits write obituaries for ... are already being felt across the world. We are ... managers have never before seen. , We need ... In that effort, Island Press and EcoAdapt are proud ... Knowledge Exchange (CAKE) at www.cakex.org . It is ...
(Date:7/29/2010)... PHILADELPHIAIn 1824, three years before he began to publish ... John James Audubon (1785-1851), the eminent artist of American ... grouse for use in the design for a New ... and the resulting engraved paper money in two separate ... locate or identify such an illustration., Now, after a ...
Breaking Biology News(10 mins):AMP responds to Genetic Test Registry request for information 2CAKE offers way forward for climate change adaptation 2Discovered: Audubon's first engraving of a bird 2EAU Completes Approval Process for Electrolyzed Water as Sanitation Process for Industrial Clean in Place Application 14057 1EAU Completes Approval Process for Electrolyzed Water as Sanitation Process for Industrial Clean in Place Application 14057 2EAU Completes Approval Process for Electrolyzed Water as Sanitation Process for Industrial Clean in Place Application 14057 3EAU Completes Approval Process for Electrolyzed Water as Sanitation Process for Industrial Clean in Place Application 14057 4Safe Routes to School Challenges Connecticut Students to Walk It and Bike It to School 57184 1Safe Routes to School Challenges Connecticut Students to Walk It and Bike It to School 57184 2Accuray Announces Additions to Board of Directors 57179 1Accuray Announces Additions to Board of Directors 57179 2Accuray Announces Additions to Board of Directors 57179 3
... Weapons Defense: Infectious Disease and Counterbioterrorism, deals with ... Press, this text is also available in e-Book. ... Army Medical Research Institute of Infectious Diseases (USAMRIID), ... 624-page, hardcover text edited by Luther E. Lindler, ...
... gene they suspect plays an important role in triggering ... century-and-a-half ago. , And the pathogen that contains this ... the modern world?on the order of billions of dollars ... Avr3a, in a study that appears online in the ...
... are in the laboratory. But those few plants are getting ... , The sugar beet industry moved out of Texas in ... But the growing research program within Texas Agricultural Experiment Station's ... said Dr. Charlie Rush, professor and director of the plant ...
Other Biology News:Researchers find gene that may be at root of potato blight 2Researchers find gene that may be at root of potato blight 3Sugar beet virus mutation requires Texas touch 2
... Clone/PAD: ZMD.478. Immunogen: Synthetic ... of the humanmouse and bovine Math-2. ... protein. Reactivity: Human Rat (positive ... rat B28 cell lysates and rat ...
...
solute carrier family 25, member 13 (citrin)...
Request Info...
Biology Products: